CD8A and neoplasm: For example, the MCPyV associated with MCC may facilitate the loss of tumor antigen expression by downregulating MHC-I subsequently resulting in impaired presentation of MCC intracellular peptides to CD8+ T lymphocytes, hence rendering tumor cells “less visible” [114,115].